CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27(kip1) with Cdk2 to cause G1 arrest in NIH 3T3 cells

Experimental Cell Research

Volumn 240, Issue 2, 1998, Pages 218-227

  Morris, T Allen ^a   Delorenzo, Robert J ^a   Tombes, Robert M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; CYCLIN D1; PROTEIN KINASE; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL GROWTH; ENZYME ACTIVATION; ENZYME INHIBITION; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0000961621     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1997.3925     Document Type: Article

References (82)

1. 2+/calmodulin-dependent protein kinase II inhibitor on cell cycle. Biochem. Biophys. Res. Commun. 199:1994;241-248.
2. Rasmussen G., Rasmussen C. Calmodulin-dependent protein kinase II is required for G1/S progression in HeLa cells. Biochem. Cell Biol. 73:1995;201-207.
3. 2+/CaM kinase. Cell Growth Differ. 6:1995;1063-1070.
4. 2+/calmodulin-dependent protein kinase inhibitor KN-62 (1--4-phenyl piperazine) in small cell lung carcinoma. Biochem. Pharmacol. 51:1996;707-715.
5. 2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 265:1990;4315-4320.
6. Boynton A. L., Whitfield J. F., Isaacs R. J., Tremblay R. The control of human WI-38 cell proliferation by extracellular calcium and its elimination by SV-40 virus-induced proliferative transformation. J. Cell Physiol. 92:1977;241-248.
7. Hazelton B., Mitchell B., Tupper J. Calcium, magnesium, and growth control in the WI-38 human fibroblast cell. J. Cell Biol. 83:1979;487-498.
8. Lu K. P., Means A. R. Regulation of the cell cycle by calcium and calmodulin. Endocr. Rev. 14:1992;40-58.
9. 2+-dependent stimulation of retinoblastoma gene product phosphorylation and p34cdc2 kinase activation in serum-stimulated human fibroblasts. J. Biol. Chem. 268:1993;138-145.
10. Means A. R. Calcium, calmodulin and cell cycle regulation. FEBS Lett. 347:1994;1-4.
11. Berridge M. J. Calcium signalling and cell proliferation. BioEssays. 17:1995;491-500.
12. Takuwa N., Zhou W., Takuwa Y. Calcium, calmodulin and cell cycle progression. Cell Signal. 7:1995;93-104.
13. 2+/calmodulin-dependent protein kinases. Annu. Rev. Biochem. 61:1992;559-601.
14. Nairn A. C., Picciotto M. R. Calcium/calmodulin-dependent protein kinases. Semin. Cancer Biol. 5:1994;295-303.
15. Picciotto M. R., Czernik A. J., Nairn A. C. Calcium/calmodulin-dependent protein kinase I: cDNA cloning and identification of autophosphorylation site. J. Biol. Chem. 268:1993;26512-26521.
16. 2+/calmodulin-dependent protein kinase V and I may form a family of isoforms. Biochem. Biophys. Res. Commun. 201:1994;1561-1566.
17. Haribabu B., Hook S. S., Selbert M. A., Goldstein E. G., Tomhave E. D., Edelman A. M., Snyderman R., Means A. R. Human calcium-calmodulin dependent protein kinase I: cDNA cloning, domain structure and activation by phosphorylation at threonine-177 by calcium-calmodulin dependent protein kinase I kinase. EMBO J. 14:1995;3679-3686.
18. Tokumitsu H., Soderling T. R. Requirements for calcium and calmodulin in the calmodulin kinase activation cascade. J. Biol. Chem. 271:1996;5617-5622.
19. Schulman H., Hanson P. I., Meyer T. Decoding calcium signals by multifunctional CaM kinase. Cell Calcium. 13:1992;401-411.
20. 2+/calmodulin-dependent protein kinase II in various cultured cells. Biomed. Res. 13:1992;173-179.
21. 2+and CaM-dependent protein kinase isoforms. Biochim. Biophys. Acta. 1221:1994;89-101.
22. Srinivasan M., Edman C. F., Schulman H. Alternative splicing introduces a nuclear localization signal that targets multifunctional CaM kinase to the nucleus. J. Cell Biol. 126:1994;839-852.
23. 2+/calmodulin-dependent protein kinase II γ-subunit variants expressed in vascular smooth muscle, brain and cardiomyocytes. J. Biol. Chem. 272:1997;9393-9400.
24. Tombes R. M., Krystal G. W. Identification of novel human tumor cell-specific CaMK-II variants. Biochim. Biophys. Acta. 1355:1997;281-292.
25. 2+/calmodulin-dependent protein kinase is necessary for nuclear envelope breakdown. J. Cell Biol. 111:1990;1763-1773.
26. 2+/calmodulin-dependent protein kinase genes in a unicellular eukaryote. EMBO J. 10:1991;1511-1522.
27. Griffith L. C., Greenspan R. J. The diversity of calcium/calmodulin-dependent protein kinase II isoforms inDrosophilais generated by alternative splicing of a single gene. FEBS Lett. 61:1993;1534-1537.
28. 2+/calmodulin-dependent protein kinase II gene. J. Biol. Chem. 268:1993;2052-2062.
29. cdc2. Dev. Growth Differ. 37:1995;589-596.
30. 2+-calmodulin-dependent protein kinase II is a binding protein for synapsin I. Nature. 359:1992;417-420.
31. Norling L. L., Colca J. R., Kelly P. T., McDaniel M. L., Landt M. Activation of calcium and calmodulin dependent protein kinase II during stimulation of insulin secretion. Cell Calcium. 16:1994;137-150.
32. Steinhardt R. A., Bi G., Alderton J. Cell membrane resealing by a vesicular mechanism similar to neurotransmitter release. Science. 263:1994;390-393.
33. Mayford M., Bach M. E., Huang Y.-Y., Wang L., Hawkins R. D., Kandel E. R. Control of memory formation through regulated expression of a CaMKII transgene. Science. 274:1996;1678-1683.
34. 2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J. 16:1997;998-1008.
35. Enslen H., Soderling T. R. Roles of calmodulin-dependent protein kinases and phosphatase in calcium-dependent transcription of immediate early genes. J. Biol. Chem. 269:1994;20872-20877.
36. 2+/calmodulin- as well as cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA. 88:1991;5061-5065.
37. (2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science. 252:1991;1427-1430.
38. Matthews R. P., Guthrie C. R., Wailes L. M., Zhao X., Means A. R., McKnight G. S. Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol. Cell. Biol. 14:1994;6107-6116.
39. 2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev. 8:1994;2527-2539.
40. Enslen H., Tokumitsu H., Soderling T. R. Phosphorylation of CREB by CaM-kinase IV activated by CaM-kinase IV kinase. Biochem. Biophys. Res. Commun. 207:1995;1038-1043.
41. 2+/calmodulin-dependent protein kinases type I, II, and IV. J. Biol. Chem. 271:1996;3066-3073.
42. Wegner M., Cao Z., Rosenfeld M. G. Calcium-regulated phosphorylation within the leucine zipper of C/EBP beta. Science. 256:1992;370-373.
43. Shimomura A., Ogawa Y., Kitani T., Fujisawa H., Hagiwara M. Calmodulin-dependent protein kinase II potentiates transcriptional activation through activating transcription factor 1 but not cAMP response element binding protein. J. Biol. Chem. 271:1996;17957-17960.
44. 2+/calmodulin-dependent kinase. Mol. Cell. Biol. 15:1995;3672-3684.
45. Valentine M. A., Czernik A. J., Rachie N., Hidaka H., Fisher C. L., Cambier J. C., Bomsztyk K. Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes. J. Exp. Med. 182:1995;1943-1949.
46. Sherr C. J. Cancer cell cycles. Science. 274:1996;1672-1677.
47. Lorca T., Cruzalegui F. H., Fesquet D., Cavadore J.-C., Méry J., Means A., Doreé M. Calmodulin-dependent protein kinase II mediates inactivation of MPF and CSF upon fertilization ofXenopuseggs. Nature. 366:1993;270-273.
48. 2+is involved through type II calmodulin-dependent protein kinase in cyclin degradation and exit from metaphase. Biochim. Biophys. Acta. 1223:1994;325-332.
49. Morin N., Abrieu A., Lorca T., Martin F., Dorée M. The proteolysis-dependent metaphase to anaphase transition: Calcium/calmodulin-dependent protein kinase II mediates onset of anaphase in extracts prepared from unfertilizedXenopuseggs. EMBO J. 13:1994;4343-4352.
50. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
51. Ewen M. E., Sluss H. K., Sherr C. J., Matsushime H., Kato J., Livingston D. M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 73:1993;487-497.
52. Frangioni J. V., Neel B. G. Solubilization and purification of enzymatically active glutathioneS-transferase (pGEX) fusion proteins. Anal. Biochem. 210:1993;179-187.
53. 2+/calmodulin-dependent protein kinase II in vascular smooth muscle cells. J. Biol. Chem. 271:1996;2506-2513.
54. Mihara K., Cao X.-R., Yen A., Chandler S., Driscoll B., Murphree A. L., T'ang A., Fung Y.-K. T. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science. 246:1989;1300-1303.
55. Ludlow J. W., Glendening C. L., Livingston D. M., DeCaprio J. A. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol. Cell Biol. 13:1993;367-372.
56. Matsushime H., Quelle D. E., Shurtleff S. A., Shibuya M., Sherr C. J., Kato J. Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell Biol. 14:1994;2066-2076.
57. Fang F., Orend G., Watanabe N., Hunter T., Ruoslahti E. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science. 271:1996;499-502.
58. 2+/calmodulin-dependent protein kinase II in intact quiescent rat 3Y1 cells. J. Biol. Chem. 263:1988;11540-11547.
59. Haystead C. M. M., Gregory P., Shirazi A., Fadden P., Mosse C., Dent P., Haystead T. A. J. Insulin activates a novel adipocyte mitogen-activated protein kinase kinase kinase that shows rapid phasic kinetics and is distinct from c-Raf. J. Biol. Chem. 269:1994;12804-12808.
60. Meyerson M., Enders G. H., Wu C.-L., Su L.-K., Gorka C., Nelson C., Harlow E., Tsai L.-H. A family of human cdc2-related protein kinases. EMBO J. 11:1992;2909-2917.
61. Resnitzky D., Reed S. I. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell. Biol. 15:1995;3463-3469.
62. Clurman B. E., Sheaff R. J., Thress K., Groudine M., Roberts J. M. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10:1996;1979-1990.
63. 2+influx in bombesin-induced mitogenesis in Swiss 3T3 fibroblasts. J. Biol. Chem. 266:1991;1403-1409.
64. 2+/calmodulin-dependent protein kinase II inhibitor KN-93. Biochem. Biophys. Res. Commun. 195:1993;608-615.
65. 2+/calmodulin-dependent protein kinase II inhibitors KN62 and KN93, and their inactive analogues KN04 and KN92, inhibit nicotinic activation of tyrosine hydroxylase in bovine chromaffin cells. Biochem. Biophys. Res. Commun. 221:1996;15-18.
66. 2+/calmodulin-dependent protein kinase II. FEBS Lett. 333:1993;315-318.
67. Baltas L. G., Karczewski P., Krause E. G. The cardiac sarcoplasmic reticulum phospholamban kinase is a distinct delta-CaM kinase isozyme. FEBS Lett. 373:1995;71-75.
68. 2+/calmodulin-dependent protein kinase isoforms in rat brain. J. Neurosci. 15:1995;6797-6808.
69. Kwiatkowski A. P., McGill J. M. Human biliary epithelial cell line Mz-ChA-1 expresses new isoforms of calmodulin-dependent protein kinase II. Gastroenterology. 109:1995;1316-1323.
70. Urquidi V., Ashcroft S. J. H. A novel pancreatic β-cell isoform of calcium/calmodulin-dependent protein kinase II (β3 isoform) contains a proline-rich tandem repeat in the association domain. FEBS Lett. 358:1995;23-26.
71. Herber B., Truss M., Beato M., Müller R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene. 9:1994;1295-1304.
72. Quelle D. E., Ashmun R. A., Shurtleff S. A., Kato J.-y., Bar-Sagi D., Roussel M. F., Sherr C. J. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1993;1559-1571.
73. Sherr C. J. D-type cyclins. Trends Biol. Sci. 20:1995;187-190.
74. King R. W., Deshaies R. J., Peters J.-M., Kirschner M. W. How proteolysis drives the cell cycle. Science. 274:1996;1652-1659.
75. Diehl J. A., Zindy F., Sherr C. J. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:1997;957-972.
76. Poon R. Y., Toyoshima H., Hunter T. Redistribution of the CDK inhibitor p27 between different cyclin·CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell. 6:1995;1197-1213.
77. Zhu X., Ohtsubo M., Bohmer R. M., Roberts J. M., Assoian R. K. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133:1996;391-403.
78. Keyomarski K., Sandoval L., Band V., Pardee A. B. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res. 51:1991;3602-3609.
79. Won K. A., Reed S. I. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15:1996;4182-4193.
80. Roussel M. F., Theodoras A. M., Pagano M., Sherr C. J. Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl. Acad. Sci. USA. 92:1995;6837-6841.
81. Desdouets C., Ory C., Matesic G., Soussi T., Bréchot C., Sobczak-Thépot J. ATF/CREB site mediated transcriptional activation and p53 dependent repression of the cyclin A promoter. FEBS Lett. 385:1996;34-38.
82. Sjaastad M. D., Lewis R. S., Nelson W. J. Mechanisms of integrin-mediated calcium signaling in MDCK cells: Regulation of adhesion by IP3- and store-independent calcium influx. Mol. Biol. Cell. 7:1996;1025-1041.